Search research articles
Contact Us
Filters
Showing results (21-30 of 75) with videos related to
Page
of 8
Sort By:
Movement Disorders : Official Journal of the Movement Disorder Society
|
November 19, 2019
CSF or serum neurofilament light added to α-Synuclein panel discriminates Parkinson's from controls
Linda P Oosterveld, Inge M W Verberk, Nour K Majbour, et al.
Alzheimer'S Research & Therapy
|
February 14, 2024
The use of synaptic biomarkers in cerebrospinal fluid to differentiate behavioral variant of frontotemporal dementia from primary psychiatric disorders and Alzheimer's disease
Shreyasee Das, Marie-Paule E van Engelen, Julie Goossens, et al.
Annals of Neurology
|
September 10, 2018
Plasma Amyloid as Prescreener for the Earliest Alzheimer Pathological Changes
Inge M W Verberk, Rosalinde E Slot, Sander C J Verfaillie, et al.
The Lancet. Healthy Longevity
|
September 13, 2022
Serum markers glial fibrillary acidic protein and neurofilament light for prognosis and monitoring in cognitively normal older people: a prospective memory clinic-based cohort study
Inge M W Verberk, Malika B Laarhuis, Karlijn A van den Bosch, et al.
Annals of Neurology
|
June 14, 2019
Serum neurofilaments as candidate biomarkers of natalizumab associated progressive multifocal leukoencephalopathy
Floor C Loonstra, Inge M W Verberk, Martijn T Wijburg, et al.
Frontiers in Neurology
|
July 25, 2025
Analytical and clinical validation of a high accuracy fully automated digital immunoassay for plasma phospho-Tau 217 for clinical use in detecting amyloid pathology
David Wilson, Meenakshi Khare, Gallen Triana-Baltzer, et al.
Neurobiology of Aging
|
October 3, 2021
BDNF-Met polymorphism and amyloid-beta in relation to cognitive decline in cognitively normal elderly: the SCIENCe project
Karlijn A van den Bosch, Inge M W Verberk, Jarith L Ebenau, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)
|
May 23, 2022
Differential diagnostic performance of a panel of plasma biomarkers for different types of dementia
Elisabeth H Thijssen, Inge M W Verberk, Jana Kindermans, et al.
JAMA Neurology
|
September 20, 2021
Head-to-Head Comparison of 8 Plasma Amyloid-β 42/40 Assays in Alzheimer Disease
Shorena Janelidze, Charlotte E Teunissen, Henrik Zetterberg, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)
|
November 25, 2024
Performance of plasma p-tau217 and NfL in an unselected memory clinic setting
Rebecca Z Rousset, Thomas Claessen, Argonde C van Harten, et al.
Page
of 8
Search research articles
Search
Showing results (21-30 of 75) with videos related to
Sort By:
Page
of 8
Movement Disorders : Official Journal of the Movement Disorder Society
|
November 19, 2019
CSF or serum neurofilament light added to α-Synuclein panel discriminates Parkinson's from controls
Linda P Oosterveld, Inge M W Verberk, Nour K Majbour, et al.
Alzheimer'S Research & Therapy
|
February 14, 2024
The use of synaptic biomarkers in cerebrospinal fluid to differentiate behavioral variant of frontotemporal dementia from primary psychiatric disorders and Alzheimer's disease
Shreyasee Das, Marie-Paule E van Engelen, Julie Goossens, et al.
Annals of Neurology
|
September 10, 2018
Plasma Amyloid as Prescreener for the Earliest Alzheimer Pathological Changes
Inge M W Verberk, Rosalinde E Slot, Sander C J Verfaillie, et al.
The Lancet. Healthy Longevity
|
September 13, 2022
Serum markers glial fibrillary acidic protein and neurofilament light for prognosis and monitoring in cognitively normal older people: a prospective memory clinic-based cohort study
Inge M W Verberk, Malika B Laarhuis, Karlijn A van den Bosch, et al.
Annals of Neurology
|
June 14, 2019
Serum neurofilaments as candidate biomarkers of natalizumab associated progressive multifocal leukoencephalopathy
Floor C Loonstra, Inge M W Verberk, Martijn T Wijburg, et al.
Frontiers in Neurology
|
July 25, 2025
Analytical and clinical validation of a high accuracy fully automated digital immunoassay for plasma phospho-Tau 217 for clinical use in detecting amyloid pathology
David Wilson, Meenakshi Khare, Gallen Triana-Baltzer, et al.
Neurobiology of Aging
|
October 3, 2021
BDNF-Met polymorphism and amyloid-beta in relation to cognitive decline in cognitively normal elderly: the SCIENCe project
Karlijn A van den Bosch, Inge M W Verberk, Jarith L Ebenau, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)
|
May 23, 2022
Differential diagnostic performance of a panel of plasma biomarkers for different types of dementia
Elisabeth H Thijssen, Inge M W Verberk, Jana Kindermans, et al.
JAMA Neurology
|
September 20, 2021
Head-to-Head Comparison of 8 Plasma Amyloid-β 42/40 Assays in Alzheimer Disease
Shorena Janelidze, Charlotte E Teunissen, Henrik Zetterberg, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)
|
November 25, 2024
Performance of plasma p-tau217 and NfL in an unselected memory clinic setting
Rebecca Z Rousset, Thomas Claessen, Argonde C van Harten, et al.
Page
of 8